WINTON GROUP Ltd Raises Stock Holdings in Inspire Medical Systems, Inc. $INSP

WINTON GROUP Ltd raised its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 790.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 37,412 shares of the company’s stock after purchasing an additional 33,212 shares during the quarter. WINTON GROUP Ltd’s holdings in Inspire Medical Systems were worth $1,669,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of INSP. BlackRock Inc. acquired a new stake in shares of Inspire Medical Systems during the second quarter worth about $211,341,000. Wellington Management Group LLP purchased a new position in Inspire Medical Systems during the 4th quarter worth approximately $203,929,000. California State Teachers Retirement System raised its position in Inspire Medical Systems by 3,720.8% during the 2nd quarter. California State Teachers Retirement System now owns 1,317,155 shares of the company’s stock worth $58,758,000 after buying an additional 1,282,682 shares during the last quarter. Deerfield Management Company L.P. lifted its stake in Inspire Medical Systems by 648.4% during the 3rd quarter. Deerfield Management Company L.P. now owns 1,047,694 shares of the company’s stock valued at $77,739,000 after acquiring an additional 907,694 shares during the period. Finally, Morgan Stanley lifted its stake in Inspire Medical Systems by 179.5% during the 4th quarter. Morgan Stanley now owns 1,259,762 shares of the company’s stock valued at $116,188,000 after acquiring an additional 809,121 shares during the period. 94.91% of the stock is owned by institutional investors and hedge funds.

Inspire Medical Systems Price Performance

Shares of NYSE INSP opened at $72.70 on Friday. The stock has a market capitalization of $2.10 billion, a price-to-earnings ratio of 15.74, a PEG ratio of 5.55 and a beta of 0.70. Inspire Medical Systems, Inc. has a 12 month low of $38.91 and a 12 month high of $147.03. The firm’s 50 day simple moving average is $57.11 and its 200-day simple moving average is $52.65.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.38. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The firm had revenue of $200.58 million during the quarter, compared to analysts’ expectations of $194.72 million. During the same period in the previous year, the business posted $0.45 EPS. The business’s revenue was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Analysts anticipate that Inspire Medical Systems, Inc. will post 1.24 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Inspire Medical Systems news, insider Jason Kelly sold 963 shares of Inspire Medical Systems stock in a transaction on Friday, August 7th. The shares were sold at an average price of $59.55, for a total value of $57,346.65. Following the completion of the transaction, the insider owned 18,985 shares of the company’s stock, valued at approximately $1,130,556.75. The trade was a 4.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on INSP. Mizuho upped their price objective on shares of Inspire Medical Systems from $55.00 to $65.00 and gave the company an “outperform” rating in a report on Tuesday, August 4th. Robert W. Baird boosted their target price on shares of Inspire Medical Systems from $54.00 to $59.00 and gave the company a “neutral” rating in a research report on Tuesday, August 4th. Truist Financial reaffirmed a “hold” rating and issued a $62.00 price target (up from $54.00) on shares of Inspire Medical Systems in a report on Tuesday, August 4th. Evercore set a $54.00 price target on Inspire Medical Systems in a research report on Tuesday, August 4th. Finally, Freedom Capital upgraded Inspire Medical Systems to a “strong-buy” rating in a research note on Tuesday, June 30th. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $66.50.

About Inspire Medical Systems

Inspire Medical Systems, Inc develops and commercializes medical devices for treating moderate to severe obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company’s primary product is Inspire therapy, an implantable system designed for patients who are unable to use or obtain consistent benefit from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses a small implantable pulse generator, a breathing-sensing lead and a stimulation lead.